Michael Gemellaro
Chief Executive Officer at Intercept Pharma Deutschland GmbH
Network origin in Michael Gemellaro first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Intercept Pharma UK & Ireland Ltd.
 Intercept Pharma UK & Ireland Ltd. Medical DistributorsDistribution Services Founded in 2015, Intercept Pharma UK & Ireland Ltd. is a pharmaceutical wholesaler. Part of Intercept Pharmaceuticals, Inc., the company is based in Bristol, UK.
3
| Subsidiary | Medical Distributors | 3 |
Intercept Pharma Deutschland GmbH
 Intercept Pharma Deutschland GmbH Medical DistributorsDistribution Services Part of Intercept Pharmaceuticals, Inc., Intercept Pharma Deutschland GmbH is a German company focused on building a healthier tomorrow for patients with progressive non-viral liver diseases. The company is based in Munich, Germany. The CEOs are Rocco Venezia, Michael Gemellaro, Willem Wouter Van Weperen. The company was founded in 2015.
2
| Subsidiary | Medical Distributors | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michael Gemellaro via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Intercept Pharma Ltd.
 Intercept Pharma Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2016, Intercept Pharma Ltd. is a British company that engages in the development and commercialization of novel therapeutics. Part of Intercept Pharmaceuticals, Inc., the company is based in Bristol, UK. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
| Kean University | College/University | Undergraduate Degree | |
| IKARIA, INC. | Biotechnology | Corporate Officer/Principal | |
Intercept Pharma Spain SLU
 Intercept Pharma Spain SLU Pharmaceuticals: MajorHealth Technology Founded in 2015, Intercept Pharma Spain SLU is a Spanish pharmaceutical company that manufactures pharmaceutical products. Part of Intercept Pharmaceuticals, Inc., the company is based in Madrid, Spain. | Pharmaceuticals: Major | Director/Board Member | |
Intercept Pharma France SAS
 Intercept Pharma France SAS Miscellaneous Commercial ServicesCommercial Services Part of Intercept Pharmaceuticals, Inc., Intercept Pharma France SAS is a French company that engages in the development and commercialization of novel therapeutics. The company is based in Paris, France. The company was founded in 2015. Patrick Charre has been the CEO of the company since 2017. | Miscellaneous Commercial Services | Director/Board Member |
Statistics
International
| United States | 4 |
| United Kingdom | 2 |
| Spain | 2 |
| France | 2 |
Sectoral
| Health Technology | 4 |
| Commercial Services | 3 |
| Consumer Services | 2 |
Operational
| Director/Board Member | 7 |
| Chief Executive Officer | 2 |
| Comptroller/Controller/Auditor | 1 |
| Director of Finance/CFO | 1 |
| Treasurer | 1 |
Most connected contacts
- Stock Market
- Insiders
- Michael Gemellaro
- Company connections
